Paternal Lymphocyte Immunization (PLI)

Paternal Lymphocyte Immunization (PLI) is an immunotherapy for women with unexplained recurrent miscarriage, designed to promote maternal tolerance of the foetus by exposing her to a small sample of her partner’s white blood cells.

During PLI, lymphocytes are collected from the father’s blood and injected into the mother—usually in several sessions timed around her menstrual cycle or following a loss—to stimulate production of protective antibodies rather than rejection responses.

Offered only after other causes of miscarriage (anatomical, hormonal, genetic, infectious) have been excluded and specialized immune tests suggest a high risk of immune‐mediated loss, PLI remains somewhat experimental but can benefit select couples under the care of a reproductive immunologist.

Overview

Paternal Lymphocyte Immunization (PLI) is an immunotherapeutic technique designed for women who experience unexplained recurrent pregnancy loss due to suspected immune rejection of the embryo. In PLI, a small sample of the father’s lymphocytes (white blood cells) is collected, processed, and then injected into the mother. This controlled exposure trains her immune system to produce “blocking” antibodies that recognize paternal antigens without mounting a destructive response. By shifting the maternal immune balance toward tolerance, PLI aims to protect the embryo during its most vulnerable early stages and reduce the risk of miscarriage.

Procedure
  1. Initial Evaluation: After ruling out anatomical, hormonal, genetic, and infectious causes of miscarriage, specialized immunological tests (e.g., natural killer cell activity, HLA compatibility) confirm suitability for PLI.
  2. Lymphocyte Collection: A blood sample is drawn from the father and sent to the laboratory.
  3. Cell Preparation: Using sterile techniques, lymphocytes are isolated, washed, and prepared in a buffered solution to ensure safety and viability.
  4. Injections: The mother receives intradermal or subcutaneous injections of the paternal lymphocyte suspension—typically three to six sessions administered at specific points in her menstrual cycle or following a loss.
  5. Monitoring: Maternal antibody titers and general health are monitored throughout the treatment period to confirm a tolerogenic response and rule out adverse reactions.
Cost of Treatment

The cost of PLI reflects multiple components: immunological workup (specialized blood tests), paternal blood collection, laboratory processing of lymphocytes, the immunization sessions themselves, and follow-up monitoring. While PLI is more resource-intensive than standard therapies, it can reduce downstream costs by preventing further miscarriage workups and failed cycles. At Abirbhav Infertility Care, we provide transparent, itemized estimates during your consultation and offer flexible financing and package plans to accommodate individual needs.

Success Rate

Published studies on PLI report live birth rates ranging from 40% to 60% in carefully selected women with recurrent pregnancy loss and immune markers of rejection. Success varies based on factors such as maternal age, underlying immune profile, and adherence to protocol. Although not universally effective, PLI has shown significant benefit for patients whose losses were immune-mediated, turning previously unsuccessful pregnancies into full-term births.

Why Choose Abirbhav Infertility Care?
  • Specialized Immunology Expertise: Our reproductive immunologists are trained in the latest PLI protocols and interpret complex immune assays for personalized care.
  • State-of-the-Art Laboratory: On-site cell-processing facilities ensure rapid, sterile preparation of lymphocytes under stringent quality control.
  • Comprehensive Evaluation: We combine full reproductive and immunological assessments to confirm PLI candidacy and optimize timing.
  • Emotional & Medical Support: From counselling through postpartum follow-up, our multidisciplinary team guides you with empathy and medical rigor at every step.
FAQs
  1. Who is a candidate for PLI?
    Women with two or more unexplained pregnancy losses, normal anatomic and genetic evaluations, and immunological markers indicating potential rejection.
  2. How many injections are required?
    Typically 3–6 sessions, timed around ovulation or shortly after a miscarriage, per your personalized protocol.
  3. Are there risks or side effects?
    Mild local reactions (redness, itching) at injection sites are common; serious reactions are rare under sterile conditions.
  4. When will I know if it’s working?
    Protective antibody levels are measured after the initial series; confirmation of immune tolerance guides ongoing care.
  5. Can PLI be combined with other treatments?
    Yes, PLI can be used alongside IVF or IUI cycles when indicated, to enhance implantation and reduce miscarriage.
  6. Is PLI covered by insurance?
    Coverage varies; our team provides detailed billing codes and documentation to assist with insurance and financing options.
Welcome To Abirbhav Infertility. Get A Free Consultation.

CALL: +91 9830767162

Paternal Lymphocyte Immunization (PLI)